The US Food and Drug Administration says its 510(k) program needs to continue modernizing to improve the safety of medical devices, especially as technology becomes more complex and innovative.
To further that effort, the FDA published three draft guidance documents on 7 September that focus on three key areas of 510(k) submissions — predicate devices, clinical data, and implantable...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?